|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's range||368.64 - 373.03|
|52-week range||260.73 - 401.78|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||16.96|
|Earnings date||03 May 2023 - 08 May 2023|
|Forward dividend & yield||2.16 (0.58%)|
|Ex-dividend date||28 Feb 2023|
|1y target est||421.31|
Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.
Despite solid product demand, Accuray (ARAY) reports an overall soft fiscal Q2 performance.
The majority of BD's (BDX) core units witness strong revenue growth in the fiscal first quarter.